Memory preservation diet™ © 2005 to reduce risk and slow progression of Alzheimer's disease (AD)

Research and Practice in Alzheimer's Disease

Volumn 11, Issue , 2006, Pages 138-159

  Emerson Lombardo, N B ^a   Volicer, L ^a   Martin, A ^a   Wu, B ^a   Zhang, X W ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Non pharmacological treatment; Nutrition; Prevention

Indexed keywords

ALPHA TOCOPHEROL; AMYLOID PRECURSOR PROTEIN; ANTIOXIDANT; APOLIPOPROTEIN E; ASCORBIC ACID; BLACK CURRANT EXTRACT; C REACTIVE PROTEIN; CALCIUM; CARNITINE; CAROTENE; CRANBERRY EXTRACT; CURCUMIN; CYANOCOBALAMIN; FOLIC ACID; GLUCOSE; GLYCOGEN SYNTHASE KINASE 3BETA; GREEN TEA EXTRACT; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MAGNESIUM; MELATONIN; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; POLYPHENOL DERIVATIVE; PROTEIN KINASE B; S ADENOSYLMETHIONINE; SELENIUM; TAU PROTEIN; THIOCTIC ACID; UNINDEXED DRUG;

ALZHEIMER DISEASE; AMINO ACID BLOOD LEVEL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; COGNITIVE DEFECT; DIABETES MELLITUS; DIET SUPPLEMENTATION; DIET THERAPY; DISEASE COURSE; DRUG POTENTIATION; EVIDENCE BASED MEDICINE; FAT INTAKE; HUMAN; HYPERTENSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIFESTYLE; MEDITERRANEAN DIET; META ANALYSIS; NONHUMAN; OBESITY; PATHOGENESIS; PRIMARY PREVENTION; RISK FACTOR; RISK REDUCTION; SYSTEMATIC REVIEW; VASCULAR DISEASE; VITAMIN BLOOD LEVEL; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION; WEIGHT REDUCTION;

EID: 33847079217     PISSN: 12848360     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (47)

1. Emerson Lombardo NB. Volicer L. Wu B. Imada T. Zhang XW. (2002). The case for life style interventions to reduce risk of Alzheimer's disease: BE[WELL program. Neurobio. Aging. 23(1s): S129.
2. Ueki A. Otsuka M. Sato T. Sasaki S. (Saitama, Japan) (2004) Nutritional approach for prevention and treatment of Alzheimer's disease - The Japanese Study. J Nutrition, Health & Aging. 8 (5):426.
3. Stolk RP. Breteler MM. Ott A. Pols HA. Lamberts SW. Grobbee DE. Hofman A. (1997) Insulin and cognitive function in an elderly population. The Rotterdam Study. Diabetes Care. 20 (5):792-5.
4. Pappolla MA. Bryant-Thomas TK. Herbert D. Pacheco J. Henry TL. Matsubara E. Zambon D. Wolozin B. Sano M. Cruz-Sanchez FF. Thal LJ. Petanceska SS. Refolo LM. (2003) Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology. Neurology. 61(2):199-205.
5. Petrovitch H. White LR. Izmirilian G. Ross GW. Havlik RJ. Markesbery W. Nelson J. Davis DG. Hardman J. Foley DJ. Launer LJ. (2000) Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS. Honolulu-Asia aging Study. Neurobiol. Aging. 21(1):57-62.
6. Schmidt R. Schmidt H. Curb JD. Masaki K. White LR. and Launer LJ.(2002) Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study. Ann. Neurol. 52(2):168-74.
7. Snowdon DA. Greiner LH. Mortimer JA. Riley KP. Greiner PA. Markesbery WR.(1997) Brain infarction and the clinical expression of Alzheimer's disease - The nun study. JAMA. 277:813-817.
8. Luchsinger JA. Reitz C. Honig LS. Tang M-X. Shea S. Mayeux R. (2005) Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology. 65:545-551.
9. Watson GS. Craft S. (2004) Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimer's disease. European Journal of Pharmacology. 490(1-3):97-113.
10. De la Monte SM. Wands JR. (2005) Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: Reference to Alzheimer's disease. J. Alzheimer's Dis. 7:45-61.
11. Diabetes prevention program research group. (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 346:393-403.
12. Panagiotakos DB. Pitsavos C. Polychronopoulos E. Chrysohoou C. Zampelas A. Trichopoulou A. (2004) Can a Mediterranean diet moderate the development and clinical progression of coronary heart disease? A systematic review. Medical Science Monitor. 10(8):RA193-8.
13. Vellas B. Lauque S. Ousset PJ (2004) Poor Nutritional Status is a Risk Factor for Rapid loss of Mini Mental State Examination (MMSE) in Alzheimer's Patients: Results of the Elsa Study. J Nutrition, Health and Aging 8 (5):424-6.
14. Morris MC. Evans DA. Bienias JL. Tangney CC. Bennett DA. Aggarwal N. Wilson RS. Scherr PA. (2002). Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a Biracial Community study. JAMA. 283(24): 3230-3237.
15. Morris MC. Evans DA. Bienias JL. Tangney CC. Bennett DA. Aggarwal N. Schneider J. Wilson RS. (2003). Dietary fats and the risk of incident Alzheimer disease. Arch. of Neurol. 60(2):194-200.
16. Kalmijn S. Launer LJ. Ott A. Witteman JC. Hofman A. Breteler MM. (1997) Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Annals of Neurology. 42(5):776-82.
17. Morris MC Evans DA. Bienias JL. Tangney CC. Bennett DA. Wilson RS. Aggarwal N. Schneider J. (2003) Consumption of fish and n-3 fatty acids and risk of incident AD. Arch of Neurology. 60(7):923-4.
18. Riggs KM. Spiro A. 3rd Tucker K. Rush D.(1996) Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study. Am J Clin Nutr. 63(3):306-14.
19. Zandi PP. Anthony JC. Khachaturian AS. Stone SV. Tschanz JT. Norton MC. Breitner JC. (2004) Re-duced risk of AD in users of antioxidant vitamin supplems: Cache County Study. Arch Neurol. 61(1):82-8.
20. Glaso M. Nordbo G. Diep L. Bohmer T. (2004) Reduced concentrations of several vitamins in normal weight patients with late-onset dementia of the Alzheimer type without vascular disease. J Nutrition, Health & Aging. 8(5):407-13.
21. Joseph JA. Shukitt-Hale B. Casadesus G. (2005 Jan.) Reversing the deleterious effects of aging on neuronal communication and behavior: beneficial properties of fruit polyphenolic compounds. [Review] [62 refs] Am J Clin Nutr. 81(1 Suppl):313S-316S.
22. Calon F. Lim GP. Yang F. Teter B. Ubeda O. Triller A. Salem N. Jr. Ashe KH. Cole GM. (2004) Docosahexaenoic acid protects from dendritic pathology in an AD mouse model. Neuron. 43 (5):633-45.
23. Shea TB. & Rogers E. (2002) Folate quenches oxidative damage in brains of apolipoprotein E-deficient mice: augmentation by vitamin E. Brain Res. Mol. Brain Res. 108: 1-6.
24. Milgram NW. Head E. Zicker SC. Ikeda-Douglas CJ. Murphey H. Muggenburg B. Siwak C. Tapp D. Cotman CW. (2005) Learning ability in aged beagle dogs is preserved by behavioral enrichment and dietary fortification: a two-year longitudinal study. Neurobiol Aging. 26: 77-90.
25. Sanchez-Moreno C. Dorfman S. Martin A. (2004) Dietary fat type affects vitamin C and E and biomarkers of oxidative stress in peripheral brain tissues of golden Syrian hampsters. Nutr Neurosci. 134:655-60.
26. Ferrucci L. Cherubini A. Bandinelli S. Bartali B. Corsi. A Martin A. Senin U. Guralnik JM.(in press) Physiologic plasma concentrations of polyunsaturated fatty acids are anti-inflammatory: InCHIANTI.
27. Frautschy SA. Hu W. Kim P. Miller SA. Chu T. Harris-White ME. Cole GM.(2001) Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology. Neurobiol Aging. 22(6):993-1005.
28. Miller ER III. Pastor-Barriuso R. Dalal D. Riemersma RA. Appel LJ. and Guallar E. (2005) Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality. Ann Intern Med. 142(1):37-46.
29. Sano M. Ernesto C. Thomas RG. et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. N Engl J Med. 1997;336:1216-1222.
30. Morris MC. Evans DA. Tangney CC. Aggarwal NT. Scherr PA. et al.(2005 Feb) Relation of the tocopherol forms to incident Alzheimer disease and to cognitive change. Am J Clin Nutr.. 81(2):508-14.
31. Okello EJ. Savelev SU. Perry EK. (2004) In vitro anti-beta-secretase and dual anti-cholinesterase activities of Camellia sinensis L. (tea) relevant to treatment of dementia. Phytother Research. 18(8):624-7.
32. Youdim KA. Martin A. Joseph JA. (2000) Essential fatty acids and the brain health implications Intl J. Devl Neurosi 18:383-399.
33. Lane RM. Farlow MR. (2005) Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease. [Review] [246 refs] J of Lipid Research. 46(5):949-68.
34. Khan A. Safdar M. Khan MMA. Khattak KN. Anderson RA. (2003) Cinnamon Improves Glucose and Lipids of People with Type 2 Diabetes. Diab Care 26:3215-3218.
35. Corrada MM. Kawas C. (2005) Reduced risk of Alzheimer's disease with high folate intake: The Baltimore Longitudinal Study of Aging. Alzheimer's & Dementia: J of Alzheimer's Association.
36. http://ods.od.nih.gov/factsheets/vitaminb12.asp
37. Institute of Medicine. (1998) Food and Nutrition Board. Dietary Reference Intakes: Thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline. National Academy Press. Washington, DC.
38. http://ods.od.nih.gov/factsheets/vitaminb6.asp
39. Broadhurst CL. Polansky MM. Anderson RA. (2000 Mar) Insulin-like biological activity of culinary and medicinal plant aqueous extracts in vitro. J Agric Food Chem.48(3):849-52.
40. Bailey CJ. Day C. (1989) Traditional plant medicines as treatments for diabetes. Diab Care 12:553-64.
41. Rabinovitz H. Friedensohn A. Leibovitz A. et al (2004) Effect of chromium supplementation on blood glucose and lipid levels in type 2 diabetes mellitus elderly patients. Intl J Vit & Nutr Res. 74(3):178-82.
42. Offenbacher EG. Rinko CJ. et al. (1985) The effects of inorganic chromium and brewer's yeast on glucose tolerance, plasma lipids, and plasma chromium in elderly subjects. Am J Clin Nutr. 42(3):454-61.
43. Cooper JL (2003) Dietary lipids in aetiology of Alzheimer's disease: implications for therapy. Drugs Aging 3:20(6): 399-418.
44. Petot GJ. Traore F. Friedland RP. et al. (2003) Interactions of apolipoprotein E genotype and dietary fat intake of healthy older persons during mid-adult life. Metabolism: Clin & Exper. 52(3):279-81.
45. Granado F. Martín A. (2003) Effect of high-pressurized orange juice consumption on plasma vitamin C, antioxidative status and inflammatory markers in healthy humans. J. Nutr. 133: 2204-2209.
46. Martin A. Joseph JA. Cuervo AM. (2002) Stimulatory effect of vitamin C on autophagy in glial cells. J Neurochemistry. 82: 538-549.
47. Lorig K. Sobel D. Stewart A. Bandura A. et al. (1999) Evidence suggesting that a chronic disease self-management program can improve health status while reducing hospitalization. Med Care. 37(2):5-14.